ID3 Promotes Stem Cell Features and Predicts Chemotherapeutic Response of Intrahepatic Cholangiocarcinoma-Reference-Cited by-同舟云学术

ID3 Promotes Stem Cell Features and Predicts Chemotherapeutic Response of Intrahepatic Cholangiocarcinoma

Published:2019-03-08 Issue:5 Volume:69 Page:1995-2012
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Huang Lifeng¹²,Cai Jie¹,Guo Han¹,Gu Jinyang¹,Tong Ying¹,Qiu Bijun¹,Wang Chenchen¹,Li Meng¹,Xia Lei¹,Zhang Jianjun¹,Wu Hailong³,Kong Xiaoni¹,Xia Qiang¹

Affiliation:

1. Department of Liver Surgery, Renji Hospital, School of Medicine Shanghai Jiao Tong University Shanghai China

2. Department of General Surgery The First Affiliated Hospital, Nanjing Medical University Nanjing China

3. Shanghai Key Laboratory for Molecular Imaging Collaborative Research Center, Shanghai University of Medicine & Health Science Shanghai China

Funder

Shanghai Municipal Education Commission

National Natural Science Foundation of China

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30404

Reference42 articles.

1. Cholangiocarcinoma

2. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma

3. Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies

4. Intrahepatic Cholangiocarcinoma

5. Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial Hepatectomy

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Membrane RRM2-positive cells represent a malignant population with cancer stem cell features in intrahepatic cholangiocarcinoma;Journal of Experimental & Clinical Cancer Research;2024-09-06

2. Silibinin is a suppressor of the metastasis-promoting transcription factor ID3;Phytomedicine;2024-06

3. YBX1 promotes stemness and cisplatin insensitivity in intrahepatic cholangiocarcinoma via the AKT/β‐catenin axis;The Journal of Gene Medicine;2024-04-27

4. Diagnostic applications and therapeutic option of Cascade CRISPR/Cas in the modulation of miRNA in diverse cancers: promises and obstacles;Journal of Cancer Research and Clinical Oncology;2023-05-24

5. m6A RNA methylation-mediated upregulation of HLF promotes intrahepatic cholangiocarcinoma progression by regulating the FZD4/β-catenin signaling pathway;Cancer Letters;2023-04